Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments. [electronic resource]
Producer: 20170703Description: 99-108 p. digitalISSN:- 1879-0852
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Clinical Trials as Topic
- Endometrial Neoplasms -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- MAP Kinase Signaling System -- physiology
- Metformin -- therapeutic use
- Molecular Targeted Therapy -- methods
- Neovascularization, Pathologic -- prevention & control
- Phosphatidylinositol 3-Kinases -- drug effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- TOR Serine-Threonine Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.